1. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

   • Yara Ruiz Garcia
   • Véronique Abitbol
   • Lamine Soumahoro

   Review Open access 30 September 2021 Pages: 639 - 655

   

2. Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

   • Yara Ruiz Garcia
   • Véronique Abitbol
   • Lamine Soumahoro

   Correction Open access 27 November 2021 Pages: 657 - 659

   

3. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

   • Ashlan J. Kunz Coyne
   • Amer El Ghali
   • Michael J. Rybak

   Review Open access 12 February 2022 Pages: 661 - 682

4. Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options

   • Carmi Bartal
   • Kenneth V. I. Rolston
   • Lior Nesher

   Review Open access 17 February 2022 Pages: 683 - 694

   

5. Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review

   • Rajamanthrilage Kasun Madusanka
   • Hermali Silva
   • Nadira D. Karunaweera

   Review Open access 22 February 2022 Pages: 695 - 711

6. Coccidioidomycosis: A Contemporary Review

   • Nancy F. Crum

   Review Open access 01 March 2022 Pages: 713 - 742

7. A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

   • Marta Díaz-Navarro
   • Rama Hafian
   • María Guembe

   Original Research Open access 16 January 2022 Pages: 743 - 755

   

8. GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

   • Iris De Ryck
   • Eleanna Sarakinou
   • Audino Podda

   Original Research Open access 03 February 2022 Pages: 757 - 770

   

9. Association of Thiamine Use with Outcomes in Patients with Sepsis and Alcohol Use Disorder: An Analysis of the MIMIC-III Database

   • Chang Hu
   • Tong Wu
   • Jianguo Li

   Original Research Open access 15 February 2022 Pages: 771 - 786

   

10. Machine Learning-Based COVID-19 Patients Triage Algorithm Using Patient-Generated Health Data from Nationwide Multicenter Database

    • Min Sue Park
    • Hyeontae Jo
    • Hyung Ju Hwang

    Original Research Open access 16 February 2022 Pages: 787 - 805

    

11. Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial

    • Sadhna Joglekar
    • Shivakumar S. Iyer
    • Shashank R. Joshi

    Original Research Open access 18 February 2022 Pages: 807 - 826

    

12. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

    • Matteo Bassetti
    • Antonio Vena
    • from the Study Group for Infections in Critically Ill Patients (ESGCIP) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

    Original Research Open access 19 February 2022 Pages: 827 - 840

13. Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

    • Stephen J. Balevic
    • Shruti M. Raja
    • Jeffrey T. Guptill

    Original Research Open access 20 February 2022 Pages: 841 - 852

    

14. Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies

    • David L. Paterson
    • Masahiro Kinoshita
    • Simon Portsmouth

    Original Research Open access 20 February 2022 Pages: 853 - 870

    

15. Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan

    • Wei-Chang Huang
    • Chih-Bin Lin
    • Chen-Yuan Chiang

    Original Research Open access 07 March 2022 Pages: 871 - 885

    

16. Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

    • Lakshmi Swaminathan
    • Scott Kaatz
    • Hallie C. Prescott

    Original Research Open access 10 March 2022 Pages: 887 - 898

    

17. EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study

    • Ryan D. Kilpatrick
    • Olga Sánchez-Soliño
    • Gregory C. Gray

    Brief Report Open access 02 February 2022 Pages: 899 - 911

    

18. Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension

    • Robert S. Brown Jr.
    • Michelle A. Collins
    • Jordan J. Feld

    Brief Report Open access 17 February 2022 Pages: 913 - 924

    

19. Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”

    • Charles Phillipe de Lucena Alves
    • Marcelo Rodrigues dos Santos
    • Daisy Motta-Santos

    Letter Open access 04 February 2022 Pages: 925 - 927

20. A Response to: Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”

    • Ricardo Salgado-Aranda

    Letter Open access 02 February 2022 Pages: 929 - 931

21. Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study

    • María Martínez-Rebollar
    • Lorena De La Mora
    • Montserrat Laguno

    Correction Open access 16 February 2022 Pages: 933 - 933

22. Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study

    • Guanhao Zheng
    • Jianxin Zhang
    • Xiaolan Bian

    Correction Open access 28 February 2022 Pages: 935 - 936